Incidence of sarcoma in patients undergoing hysterectomy for benign indications: a population-based study.

ABSTRACT:

Background

Minimally invasive hysterectomy may require the use of morcellation to remove the uterus. In the presence of unexpected sarcoma, morcellation risks disseminating malignant cells and worsening survival outcomes. As a consequence, in 2014 the US Food and Drug Administration issued a black box warning against the use of power morcellator for the treatment of uterine fibroids. However, the proportion of unexpected sarcoma at the time of hysterectomy for presumed benign indication remains unclear.

Objective

The objective of the study was to estimate the incidence of sarcoma among women undergoing hysterectomy for benign indication in Olmsted County, MN, between 1999 and 2013.

Study design

We conducted a population-based study including all hysterectomies perform

SUBMITTER: Multinu F 

PROVIDER: S-EPMC7118695 | biostudies-literature | 2019 Feb

REPOSITORIES: biostudies-literature